• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非艾滋病疫苗给艾滋病疫苗研发带来的经验教训。

Lessons for AIDS vaccine development from non-AIDS vaccines.

作者信息

Clements-Mann M L

机构信息

Center for Immunization Research, Department of International Health, School of Hygiene and Public Health, Johns Hopkins University, Baltimore, Maryland 21205, USA.

出版信息

AIDS Res Hum Retroviruses. 1998 Oct;14 Suppl 3:S197-203.

PMID:9814944
Abstract

Critical misconceptions about vaccine development have arisen in the context of acquired immunodeficiency syndrome (AIDS) vaccine research. These include: the goal of vaccination; the biological relevance and predictive value of animal models; the meaning of "correlates of protective immunity"; the nature and duration of vaccine-induced immune responses; and the need for multiple, iterative field trials. In this article, lessons from the history of successful vaccine development relevant to these issues are discussed. Clarity about these central issues and adherence to a common vocabulary are important for the process of establishing an appropriate, milestone-driven process for developing safe, effective AIDS vaccines.

摘要

在获得性免疫缺陷综合征(艾滋病)疫苗研究背景下,出现了有关疫苗研发的严重误解。这些误解包括:疫苗接种的目标;动物模型的生物学相关性和预测价值;“保护性免疫相关因素”的含义;疫苗诱导免疫反应的性质和持续时间;以及进行多次迭代现场试验的必要性。本文讨论了与这些问题相关的成功疫苗研发历史中的经验教训。明确这些核心问题并坚持使用通用词汇,对于建立一个合适的、以里程碑为驱动的流程来开发安全有效的艾滋病疫苗至关重要。

相似文献

1
Lessons for AIDS vaccine development from non-AIDS vaccines.非艾滋病疫苗给艾滋病疫苗研发带来的经验教训。
AIDS Res Hum Retroviruses. 1998 Oct;14 Suppl 3:S197-203.
2
AIDS vaccine development: the long and winding road.艾滋病疫苗研发:漫长而曲折的道路。
AIDS Rev. 2003 Jul-Sep;5(3):131-9.
3
Update on HIV vaccines.HIV疫苗的最新情况。
STEP Perspect. 1997 Summer;9(2):5-6, 8-9.
4
Predictive value of primate models for AIDS.灵长类动物模型对艾滋病的预测价值。
AIDS Rev. 2004 Oct-Dec;6(4):187-98.
5
The development of an AIDS vaccine: progress and promise.艾滋病疫苗的研发:进展与前景。
Public Health Rep. 1988 May-Jun;103(3):230-6.
6
HIV/AIDS vaccines: a need for new concepts?艾滋病毒/艾滋病疫苗:是否需要新的概念?
Int Rev Immunol. 2008;27(6):447-71. doi: 10.1080/08830180802432160.
7
A review of vaccine research and development: the human immunodeficiency virus (HIV).疫苗研发综述:人类免疫缺陷病毒(HIV)
Vaccine. 2006 May 8;24(19):4062-81. doi: 10.1016/j.vaccine.2006.02.031. Epub 2006 Feb 28.
8
An HIV vaccine: how and when?一种艾滋病疫苗:如何研发以及何时问世?
Bull World Health Organ. 2001;79(12):1133-7.
9
Obstacles and progress toward development of a preventive HIV vaccine.
J Int Assoc Physicians AIDS Care. 1997 Aug;3(8):28-34.
10
Recent advances in AIDS vaccine research and development.艾滋病疫苗研发的最新进展。
AIDS Res Hum Retroviruses. 1994;10 Suppl 2:S317-23.

引用本文的文献

1
The SARS-CoV-2 mutations versus vaccine effectiveness: New opportunities to new challenges.SARS-CoV-2 突变与疫苗效力:新机遇与新挑战。
J Infect Public Health. 2022 Feb;15(2):228-240. doi: 10.1016/j.jiph.2021.12.014. Epub 2022 Jan 5.
2
Predicting Overall Vaccine Efficacy in a New Setting by Re-Calibrating Baseline Covariate and Intermediate Response Endpoint Effect Modifiers of Type-Specific Vaccine Efficacy.通过重新校准特定类型疫苗效力的基线协变量和中间反应终点效应修饰因子来预测新环境中的总体疫苗效力。
Epidemiol Methods. 2016 Dec;5(1):93-112. doi: 10.1515/em-2015-0007. Epub 2016 Jan 23.
3
A Bayesian approach to estimating causal vaccine effects on binary post-infection outcomes.
一种用于估计因果疫苗对二元感染后结局影响的贝叶斯方法。
Stat Med. 2016 Jan 15;35(1):53-64. doi: 10.1002/sim.6573. Epub 2015 Jul 20.
4
Fold rise in antibody titers by measured by glycoprotein-based enzyme-linked immunosorbent assay is an excellent correlate of protection for a herpes zoster vaccine, demonstrated via the vaccine efficacy curve.通过基于糖蛋白的酶联免疫吸附测定法测得的抗体滴度的倍增是带状疱疹疫苗保护效果的良好指标,这在疫苗效力曲线中得到了证实。
J Infect Dis. 2014 Nov 15;210(10):1573-81. doi: 10.1093/infdis/jiu279. Epub 2014 May 13.
5
New clinical trial designs for HIV vaccine evaluation.新型 HIV 疫苗评估临床试验设计。
Curr Opin HIV AIDS. 2013 Sep;8(5):437-42. doi: 10.1097/COH.0b013e328363d46a.
6
In pursuit of an HIV vaccine: designing efficacy trials in the context of partially effective nonvaccine prevention modalities.追求艾滋病疫苗:在部分有效的非疫苗预防方式背景下设计疗效试验。
AIDS Res Hum Retroviruses. 2013 Nov;29(11):1513-23. doi: 10.1089/aid.2012.0385. Epub 2013 Jun 25.
7
Causal Vaccine Effects on Binary Postinfection Outcomes.因果性疫苗对感染后二元结局的影响。
J Am Stat Assoc. 2006 Mar;101(473):51-64. doi: 10.1198/016214505000000970.
8
Evaluating a surrogate endpoint at three levels, with application to vaccine development.在三个层面评估替代终点及其在疫苗研发中的应用。
Stat Med. 2008 Oct 15;27(23):4758-78. doi: 10.1002/sim.3122.